Edition:
United States

MorphoSys AG (MORG.DE)

MORG.DE on Xetra

92.35EUR
4:02am EDT
Change (% chg)

€0.45 (+0.49%)
Prev Close
€91.90
Open
€92.30
Day's High
€92.75
Day's Low
€92.00
Volume
16,925
Avg. Vol
136,350
52-wk High
€124.90
52-wk Low
€70.31

Chart for

About

MorphoSys AG develops and commercializes antibodies for therapeutic applications. The Company develops drugs using its own research and development, as well as in cooperation with pharmaceutical and biotechnology partners. The Company's operating segments include Proprietary Development and Partnered Discovery. In the Proprietar... (more)

Overall

Beta: 0.75
Market Cap(Mil.): €2,926.06
Shares Outstanding(Mil.): 31.84
Dividend: --
Yield (%): --

Financials

  MORG.DE Industry Sector
P/E (TTM): -- 109.17 32.55
EPS (TTM): -2.76 -- --
ROI: -17.99 1.47 12.80
ROE: -18.34 0.22 14.92

German stocks - Factors to watch on September 13

BERLIN, Sept 13 The following are some of the factors that may move German stocks on Thursday:

Sep 13 2018

Novartis to pay 95 million euros to Galapagos, MorphoSys for skin drug

ZURICH Novartis said on Thursday it will pay 95 million euros ($110.49 million) to Galapagos and MorphoSys to license a prospective medicine targeting the skin condition atopic dermatitis, as the Swiss drugmaker strengthens its foothold in immunology.

Jul 19 2018

Novartis to pay 95 mln euros to Galapagos, MorphoSys for skin drug

ZURICH, July 19 Novartis said on Thursday it will pay 95 million euros ($110.49 million) to Galapagos and MorphoSys to license a prospective medicine targeting the skin condition atopic dermatitis, as the Swiss drugmaker strengthens its foothold in immunology.

Jul 19 2018

German stocks - Factors to watch on July 11

BERLIN/FRANKFURT, July 11 The following are some of the factors that may move German stocks on Wednesday:

Jul 11 2018

German stocks - Factors to watch on June 13

FRANKFURT/BERLIN, June 13 The following are some of the factors that may move German stocks on Wednesday:

Jun 13 2018

German stocks - Factors to watch on May 17

BERLIN/FRANKFURT, May 17 The following are some of the factors that may move German stocks on Thursday:

May 17 2018

BRIEF-Morphosys AG Reports Q1 Revenue Of 2.8 Million EUR

* Q1 REVENUE 2.8 MILLION EUR VERSUS 11.8 MILLION EUR YEAR AGO

May 02 2018

BRIEF-Morphosys, Galapagos initiate IGUANA phase 2 clinical trial with Mor106 in Atopic Dermatitis patients

* DGAP-NEWS: MORPHOSYS AND GALAPAGOS ANNOUNCE INITIATION OF THE IGUANA PHASE 2 CLINICAL TRIAL WITH MOR106 IN ATOPIC DERMATITIS PATIENTS

May 01 2018

BRIEF-MorphoSys Announces Approval Of Tremfya(R)In South Korea

* DGAP-NEWS: MORPHOSYS ANNOUNCES APPROVAL OF TREMFYA(R) (GUSELKUMAB) IN SOUTH KOREA

Apr 26 2018

BRIEF-Morphosys Says NASDAQ IPO Leads To Total Gross Proceeds Of USD 239 Million

* DGAP-NEWS: MORPHOSYS ANNOUNCES CLOSING OF NASDAQ IPO THROUGH AN ADS OFFERING AND EXERCISE OF THE UNDERWRITERS' OPTION TO PURCHASE ADDITIONAL ADSS, LEADING TO TOTAL GROSS PROCEEDS OF USD 239 MILLION

Apr 23 2018

Earnings vs. Estimates